Vanguard Health Care Index Fund
Price through Oct 1 · Flows through Oct 31. Figures use the latest available records, not a live quote. Fund details retrieved Oct 1. Holdings snapshot retrieved Oct 1.
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1Y SHOWN
Recent fund-flow records are unavailable, while the price has returned +8.3% so far this year. At 0.10% a year, no lower reported fee appears among the alternatives shown here.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 12.82% | $1149.85 | -0.6% | ||
| 2 | JNJJOHNSON & JOHNSON | 8.74% | $258.66 | -2.3% | ||
| 3 | ABBVABBVIE | 6.27% | $259.93 | -0.6% | ||
| 4 | MRKMERCK & CO | 5.05% | $143.81 | -1.0% | ||
| 5 | UNHUNITEDHEALTH GROUP | 4.90% | $365.20 | -0.5% | ||
| 6 | TMOTHERMO FISHER SCIENTIFIC | 3.18% | $652.51 | -3.3% | ||
| 7 | AMGNAMGEN | 3.21% | $407.27 | -3.4% | ||
| 8 | GILDGILEAD SCIENCES | 2.52% | $147.50 | -1.0% | ||
| 9 | ABTABBOTT LABORATORIES | 2.66% | $96.69 | -2.2% | ||
| 10 | PFEPFIZER | 2.25% | $28.12 | -1.4% | ||
| 11 | ISRGINTUITIVE SURGICAL | 1.85% | $401.24 | -1.3% | ||
| 12 | DHRDANAHER | 1.88% | $211.76 | -4.4% | ||
| 13 | VRTXVERTEX PHARMACEUTICALS | 1.91% | $506.74 | -3.1% | ||
| 14 | BMYBRISTOL MYERS SQUIBB | 1.89% | $61.46 | -1.5% | ||
| 15 | MDTMEDTRONIC | 1.61% | $86.44 | +0.2% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 412| 1 week | -2.5% |
| 1 month | -3.1% |
| 3 months | +3.6% |
| 6 months | +17.0% |
| YTD | +8.3% |
| 1 year | +16.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 12.8% of the book; the top ten carry 52%. Spread across 250+ names, it behaves like roughly 24 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $35M | $34M |
| LLY ELI LILLY | $30M | $32M |
| UNH UNITEDHEALTH GROUP | $23M | $22M |
| LQDA LIQUIDIA | $13M | $17M |
| MDT MEDTRONIC | $4M | $11M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat VHT on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.5B | +$286M | -7bp on fee · 2× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.2B | +$199M | -7bp on fee · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.9B | +$497M | -6bp on fee · 2× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$575M | -6bp on fee · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -6bp on fee · +$412M in over the month | Head-to-head |